Xcout IntelSign inSubscribe

VentriPoint Diagnostics Ltd. competitors & alternatives

VPTMedical - DevicesToronto, Canada

The 12 closest competitors and alternatives to VentriPoint Diagnostics Ltd. among medical - devices companies — ranked by similarity to what VentriPoint Diagnostics Ltd. actually does, not by market-cap band.

$14.7MMarket cap
10Employees
12Competitors listed

Subscribe to see VentriPoint Diagnostics Ltd.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About VentriPoint Diagnostics Ltd.

VentriPoint Diagnostics Ltd. is a medical technology company focused on developing and commercializing diagnostic tools worldwide. These innovative solutions are designed to monitor individuals afflicted with cardiovascular disease. At the core of their offerings is the Ventripoint Medical System (VMS), an advanced medical imaging platform. The VMS generates precise three-dimensional models of the heart's chambers, providing crucial volumetric and functional measurements. This system is further enhanced by its VMS+ software, which processes echocardiogram and magnetic resonance imaging (MRI) data to construct these 3D models. The VMS+ software ensures highly reproducible and accurate quantification of heart chamber volumes and ejection fraction. Beyond its current flagship system, VentriPoint Diagnostics is actively expanding its portfolio with a suite of specialized applications. These applications target various cardiac conditions and imaging techniques, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and heart complications stemming from Covid-19. Founded in 2004, the company operates from its headquarters in Toronto, Canada.

VentriPoint Diagnostics Ltd. at a glance

VentriPoint Diagnostics Ltd. is a medical - devices company headquartered in Toronto, Canada. It is publicly listed (VPT) with a market capitalisation of $14.7M. Xcout tracks 6 named people at VentriPoint Diagnostics Ltd., including Hugh MacNaught (CEO, Director).

VentriPoint Diagnostics Ltd. leadership

  • Hugh MacNaughtCEO, Director
  • David SwetlowCFO
  • Dr. George AdamsChairman, Member of Nominating & Corporate Governance & Audit Committees
  • Matt DobsonMarketing Director
  • Fiona FitzgeraldDirector
  • Randy AuCoinDirector

Top 12 VentriPoint Diagnostics Ltd. competitors

Ranked by semantic similarity — how close each company is to VentriPoint Diagnostics Ltd. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

Butterfly Network, Inc.BFLY · Medical - DevicesBurlington, United States
65% matchPublic

Similar medical - devices company

Butterfly Network, Inc. functions as a digital health enterprise, specializing in the invention, production, and global commercialization of cutting-edge ultrasound imaging technologies for both domestic and international markets. The company's innovative product portfolio includes the portable Butterfly iQ, a versatile single-probe system capable of whole-body ultrasound imaging, and the Butterfly iQ+, a point-of-care ultrasound device engineered to connect effortlessly with smartphones, tablets, and existing hospital computer networks. Additionally, Butterfly Blueprint is offered as a comprehensive, system-wide ultrasound platform that seamlessly integrates its proprietary Compass software into a healthcare provider's clinical and administrative infrastructure. These ultrasound systems, encompassing probes, related accessories, and software subscriptions, are supplied to healthcare systems, individual physicians, and other medical professionals through a multi-channel distribution strategy that includes a direct sales force, a network of distributors, and an e-commerce platform. Beyond its hardware, Butterfly Network provides a suite of cloud-based software solutions for healthcare organizations. These offerings feature teleguidance services, interactive in-app educational modules, and structured training programs delivered via its Butterfly Academy software, all complemented by dedicated clinical support and services. Established in 2011, Butterfly Network, Inc. has its corporate headquarters situated in Guilford, Connecticut.

Market cap$2.1B
Employees220
Butterfly Network, Inc. competitors & alternatives →
GE HealthCareGEHC · Medical DevicesChicago, United States
63% matchPublic

Medical Devices

GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.

Market cap$29B
Employees54,000
GE HealthCare competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of VentriPoint Diagnostics Ltd. and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for VentriPoint Diagnostics Ltd.and every competitor above — in one live dashboard.

Subscribe to Xcout Intel →